Manipulating Ghrelin Signaling Via GOAT Inhibition in Alcohol Use Disorder

NCT03896516 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

21

Enrollment

NIH

Sponsor class

Conditions

Alcohol Use Disorder

Interventions

OTHER: Placebo
DRUG: GLWL-01

Sponsor

National Institute on Drug Abuse (NIDA)